Leigh Page Physicians who misuse the “copy-and-paste” feature in patients’ electronic health records (EHRs) can face serious consequences, including lost hospital privileges, fines, and malpractice lawsuits. In California, a locum tenens physician lost her hospital privileges after repeatedly violating the copy-and-paste policy developed at Santa Rosa Memorial Hospital, Santa Rosa, California. “Her use of copy...
Category: <span>Clinical Practice</span>
FDA adds Fasenra indication for severe asthma in children
by Lori Solomon The U.S. Food and Drug Administration has approved an additional indication for AstraZeneca’s Fasenra (benralizumab) as an add-on maintenance treatment for patients aged 6 to 11 years with severe asthma and an eosinophilic phenotype. This indication was supported by evidence from the Phase III TATE trial, as well as data from additional...
What are the links between liver disease and the microbiome?
Content by Owlstone Medical LtdReviewed by Louis Castel The gut-liver axis is the term used to describe the two-way relationship between the gut microbiome and the liver. This relationship stems from the integration of signals produced by various factors such as diet, genetics, and the environment. The liver and the gastrointestinal tract are connected by...
Forget Bats And Rats, This ‘Animal’ Spreads More Viruses Than Any Other
A new study reveals a surprising fact: humans are actually spreading more viruses to animals than we receive from them.Edited by Nikhil Pandey Humans pass on more viruses to domestic and wild animals than we catch from them. For years, animals like rats and bats have been blamed for spreading diseases to humans. However, a...
Can a cup of tea keep COVID away? Study demonstrates that certain teas inactivate SARS-CoV-2 in saliva
by Jennifer L Reynolds, University of Georgia cup of teaCredit: Pixabay/CC0 Public DomainNew research from the University of Georgia suggests that something as simple as a cup of tea can help in the fight against COVID-19. Tea has been renowned globally for its many health benefits, and Malak Esseili, a virologist with the University of...
Five Keys to Helping Long-COVID Patients Recover
About 7% of US adults report having or having had symptoms of long COVID such as fatigue, heart palpitations and/or dizziness. These are three of the 12 symptoms identified as part of the National Institute of Health’s RECOVER initiative that can be reliably used to classify someone as having long COVID. While there is no...
Focal Therapy for Prostate Cancer: Evidence-Based or Oversold?
Howard Wolinsky In 2013, a prostate-specific antigen (PSA) blood test revealed that Richard LaFrate’s levels had jumped. Previously in a normal range, LaFrate’s PSA was now above 6 ng/mL, indicating an elevated likelihood for prostate cancer. The jazz guitarist from Leesburg, Florida, then 70 years old, underwent a biopsy, which found two Gleason 6 lesions....
New Guidelines: Start PSA Screening Earlier in Black Men
Lowering the recommended age for baseline prostate-specific antigen (PSA) would reduce prostate cancer deaths by about 30% in Black men without significantly increasing the rate of overdiagnosis, according to new screening guidelines from the Prostate Cancer Foundation. Specifically, baseline PSA testing in Black men should begin at age 40-45, sooner than current guidelines recommend, and...
GLP-1s Don’t Appear to Worsen Diabetic Retinopathy
Richard Mark Kirkner SAN FRANCISCO ― A large observational registry study of almost 100,000 eyes has found that the diabetes drug semaglutide, a GLP-1 agonist recently approved for weight loss, does not worsen the progression of potentially vision-threatening diabetic retinopathy in the long term in patients taking the drug. However, the researchers said, the findings...
SGLT2 Inhibitors Protective Against Retinopathy in T2D
TOPLINE:Sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with a lower risk for sight-threatening retinopathy than other second-line glucose-lowering medications in patients with type 2 diabetes (T2D). METHODOLOGY:Researchers conducted a nationwide cohort study including 3,544,383 patients with newly diagnosed T2D.During the 5-year study period, 159,965 patients were treated with SGLT2 inhibitors, 304,383 received dipeptidyl peptidase-4 (DPP-4)...